1. Home
  2. VERV vs HONE Comparison

VERV vs HONE Comparison

Compare VERV & HONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • HONE
  • Stock Information
  • Founded
  • VERV 2018
  • HONE 1917
  • Country
  • VERV United States
  • HONE United States
  • Employees
  • VERV N/A
  • HONE N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • HONE Major Banks
  • Sector
  • VERV Health Care
  • HONE Finance
  • Exchange
  • VERV Nasdaq
  • HONE Nasdaq
  • Market Cap
  • VERV 475.0M
  • HONE 529.8M
  • IPO Year
  • VERV 2021
  • HONE 2016
  • Fundamental
  • Price
  • VERV $5.50
  • HONE $12.94
  • Analyst Decision
  • VERV Strong Buy
  • HONE Hold
  • Analyst Count
  • VERV 4
  • HONE 1
  • Target Price
  • VERV $25.75
  • HONE $13.00
  • AVG Volume (30 Days)
  • VERV 1.6M
  • HONE 231.4K
  • Earning Date
  • VERV 11-05-2024
  • HONE 01-28-2025
  • Dividend Yield
  • VERV N/A
  • HONE 2.48%
  • EPS Growth
  • VERV N/A
  • HONE N/A
  • EPS
  • VERV N/A
  • HONE 0.27
  • Revenue
  • VERV $24,396,000.00
  • HONE $158,656,000.00
  • Revenue This Year
  • VERV $97.47
  • HONE N/A
  • Revenue Next Year
  • VERV N/A
  • HONE $9.50
  • P/E Ratio
  • VERV N/A
  • HONE $46.93
  • Revenue Growth
  • VERV 219.91
  • HONE N/A
  • 52 Week Low
  • VERV $4.31
  • HONE $9.16
  • 52 Week High
  • VERV $19.34
  • HONE $14.00
  • Technical
  • Relative Strength Index (RSI)
  • VERV 44.33
  • HONE 50.15
  • Support Level
  • VERV $5.19
  • HONE $12.71
  • Resistance Level
  • VERV $7.40
  • HONE $13.11
  • Average True Range (ATR)
  • VERV 0.65
  • HONE 0.29
  • MACD
  • VERV -0.12
  • HONE -0.03
  • Stochastic Oscillator
  • VERV 7.88
  • HONE 48.61

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About HONE HarborOne Bancorp Inc.

HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in each of Boston, Massachusetts and Providence, Rhode Island.

Share on Social Networks: